Rilpivirine Hydrochloride News
Rilpivirine Hydrochloride currently has 2 news articles, with 20 predicted indications.
This page combines the AI-predicted indications for Rilpivirine Hydrochloride with the latest health news. Indications highlighted in orange have recent news coverage.
Drug Information
- Original indication: Treatment of adults and adolescents (aged 12 years and older with body weight at least 35 kg) infected with human immunodeficiency virus 1 (HIV 1) without known mutations associated with resistance...
- Evidence level: L5
- Predicted indications (20):
- HIV infectious disease (100.0%)
- feline acquired immunodeficiency syndrome (100.0%)
- simian immunodeficiency virus infection (100.0%)
- neurodevelopmental disorder with ataxic gait, absent speech, and decreased cortical white matter (100.0%)
- AIDS (99.8%)
- congenital human immunodeficiency virus (99.6%)
- AIDS related complex (99.6%)
- obsolete familial combined hyperlipidemia (98.6%)
- chronic hepatitis C virus infection (95.2%)
- fibroma of prostate (93.9%)
- benign reproductive system neoplasm (93.2%)
- Brenner tumor (93.2%)
- benign prostate phyllodes tumor (92.8%)
- male reproductive organ cancer (91.5%)
- prostate leiomyoma (90.2%)
- prostate cancer/brain cancer susceptibility (89.9%)
- hepatitis C virus infection (86.7%)
- hepatitis B virus infection (85.8%)
- hepatitis E virus infection (83.4%)
- hepatitis, viral, animal (83.3%)
Related News (2)
Controversial vaccine trial touted by RFK Jr gets go-ahead in Guinea-Bissau - The Guardian
2026-10-09 hepatitis
Source: The Guardian
Meteo estremo, cibo contaminato, ricoveri lunghi. A Roma è boom di Epatite A: perché c’è da preoccuparsi
2026-10-08 epatite
Source: RomaToday
Disclaimer: The news on this page is collected automatically and is for research reference only; it does not constitute medical advice.